Creative Medical Technology (OTCMKTS:CELZ) Stock Passes Below 50-Day Moving Average of $0.73

Shares of Creative Medical Technology Holdings, Inc. (OTCMKTS:CELZGet Rating) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.73 and traded as low as $0.71. Creative Medical Technology shares last traded at $0.74, with a volume of 227,641 shares changing hands.

Creative Medical Technology Stock Up 1.3 %

The business’s 50 day moving average price is $0.73 and its 200-day moving average price is $1.61.

Hedge Funds Weigh In On Creative Medical Technology

A number of hedge funds have recently made changes to their positions in the business. UBS Group AG bought a new stake in shares of Creative Medical Technology in the 1st quarter worth about $36,000. Citigroup Inc. bought a new stake in shares of Creative Medical Technology in the 1st quarter worth about $47,000. XTX Topco Ltd bought a new stake in shares of Creative Medical Technology in the 1st quarter worth about $68,000. State Street Corp bought a new stake in shares of Creative Medical Technology in the 1st quarter worth about $90,000. Finally, Perkins Capital Management Inc. bought a new stake in shares of Creative Medical Technology in the 4th quarter worth about $52,000. Institutional investors and hedge funds own 13.66% of the company’s stock.

Creative Medical Technology Company Profile

(Get Rating)

Creative Medical Technology Holdings, Inc, a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility.

Recommended Stories

Want More Great Investing Ideas?

Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.